We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.
Cookie consent is provided in English only for legal validity.

GB MCL & CLP Screening: Is Your Classification Still Right on Both Sides of the Channel?

If you place mixtures on the market in Great Britain and in the EU, you are now working to two diverging rulebooks. The GB mandatory classification list moves on its own schedule, the EU's harmonised classifications move on theirs, and a label that was right when the product launched can quietly become wrong in one market without anything changing in your factory.

Why this drifted apart

Before Brexit there was one list: the harmonised classifications in Annex VI of EU CLP, updated by successive adaptations. Great Britain now runs its own regime — GB CLP — with its own mandatory classification list maintained by HSE and updated in its own editions. The two started identical and have been diverging ever since: substances added on one side but not the other, and substances where the two regimes reach different conclusions. Northern Ireland, under the Windsor Framework arrangements, continues to follow EU CLP, which is a third complication for UK-wide sellers.

What divergence does to a formulator

  • Mixture classification changes without a reformulation. Your product's classification is calculated from its ingredients. When an ingredient's mandatory classification changes in one regime, the mixture's classification, label and SDS can change in that market — while remaining untouched in the other.
  • Two-market products need two checks. A GB label and an EU label for the same drum may legitimately differ, and each must match its own rulebook, not the other's.
  • Downstream documents lag. Safety data sheets, transport documentation and workplace COSHH assessments all inherit the classification. A missed update propagates.
  • Customers notice before regulators do. Large buyers screen supplier SDSs; a stale classification reads as a competence signal, fairly or not.

What the screen involves

You send us the formulations (under NDA as standard) for up to five high-volume products. We check each ingredient against the current GB MCL editions and against the current EU harmonised classifications, recalculate where a divergence touches your mixture, and report per product: current correct classification in each market, what changed and when, and exactly which documents need updating. Where nothing has moved, the report says so — a clean bill of health you can file as evidence of regulatory surveillance, which is precisely what an ISO 14001 compliance-obligations evaluation wants to see.

This is deliberately a screen, not a retainer. Most formulators need a competent periodic check, not a permanent subscription. If the screen finds real work, we quote it separately and you decide.

Where this meets your ISO system

Classification surveillance is a compliance obligation under ISO 14001 and a product-requirements input under ISO 9001 — auditors increasingly ask how you keep up with GB MCL editions, and "our SDS provider handles it" is a weak answer when the SDS provider was never told the formulation changed. The screen's report slots into your compliance evaluation records directly. For the wider picture on how regulatory work and the EMS should share one spine, see ISO for chemical and process manufacturers.

The GB MCL Rapid Screen

A fixed £450: we review up to five of your high-volume formulations against the current GB MCL editions, flag where GB and EU classification have diverged for your ingredients, and tell you which labels, safety data sheets and downstream documents need attention. Run by a chemical engineer who reads classification tables for a living, not a subscription database on autopilot.